such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos ...

Anthony Petrone’s rating is based on several promising developments regarding LivaNova’s OSPREY study for treating obstructive sleep apnea (OSA). The company announced favorable 6-month results from ...

There is a lot of research out there, including clinical trials, aimed at combating sleep apnea, a serious sleep disorder.

An unhealthy diet and an indolent life are well known causes of heart disease and stroke. But sleep apnea—where people ...

LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.

LivaNova today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary endpoints.

A Veteran from the Brazos Valley faced the darkest parts of his mind after serving in the US military. He says a device for ...

The global sleep study market is poised for remarkable expansion, with projections indicating a surge in value from USD 6,754 ...

Climate change is increasingly disrupting people’s sleep. High nighttime temperatures led to 5% more hours of sleep lost worldwide over the past five years compared to the period between 1986 ...

TALLAHASSEE, Fla., Oct. 29, 2024 /PRNewswire/ -- Dylan Petkus, MD, leading sleep apnea expert and founder of Optimal Circadian Health, is releasing a new book that's set to shake up the sleep ...

DEAR SAM: I’m sorry to hear your CPAP mask is keeping you awake at night, but I’m happy to hear that you’re addressing your obstructive sleep apnea (OSA) problem. Left untreated, OSA is linked to ...

"This may be indicative of an underlying disorder, such as obstructive sleep apnea, and intervention may improve both quality of life and overall health." The study was funded by the National ...